Anjali Verma

Employment

• University of North Carolina at Chapel Hill Postdoctoral Research Associate
  2019 - Present
• Virginia Commonwealth University Teaching Assistant
  2016 - 2018
• Virginia Commonwealth University Research Assistant
  2014 - 2019

Education

• Virginia Commonwealth University Ph.D.
  2015 - 2019
• Case Western Reserve University B.S.
  2009 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• MiR-101a loaded extracellular Nanovesicles as bioactive carriers for cardiac repair
  Nanomedicine: Nanotechnology, Biology and Medicine 2020 DOI: 10.1016/j.nano.2020.102201
  +Save
• Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma
  Scientific Reports 2020 DOI: 10.1038/s41598-020-60675-2
  +Save
• Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer
  Steroids 2019 DOI: 10.1016/j.steroids.2019.108498
  +Save
• 24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo
  Biochimica et Biophysica Acta (BBA) - General Subjects 2019 DOI: 10.1016/j.bbagen.2019.05.013
  +Save
• 24R,25-dihydroxyvitamin D3 modulates tumorigenicity in breast cancer in an estrogen receptor-dependent manner
  Steroids 2019 DOI: 10.1016/j.steroids.2019.108447
  +Save
• 24R,25(OH)2D3, a metabolite of vitamin D3, is differentially tumorigenic in ER+ and ER- breast cancer
  American Association for Cancer Research 2019
  +Save
• Estradiol receptor profile and estrogen responsiveness in laryngeal cancer and clinical outcomes
  Steroids 2019 DOI: 10.1016/j.steroids.2017.11.012
  +Save
• 24R,25-dihydroxyvitamin D3 reduces tumor burden and metastasis in ER+ breast cancer in vivo
  American Association of Cancer Research 2018
  +Save
• 17β-Estradiol modulates laryngeal carcinoma growth through variably-expressed membrane-associated ERs
  American Association of Dental Research 2018
  +Save
• 24R,25(OH)2D3, a novel metabolite of vitamin D3, had a differentially tumorigenic effect in ER+ and ER- breast cancer
  Biomedical Engineering Society 2018
  +Save